Retatrutide is an experimental drug for obesity. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors).\u00a0Retatrutide has been studied in a phase 2 trial involving adults without diabetes but with obesity or preobesity (overweight). Retatrutide is also being evaluated in phase 3 clinical trials. A substudy in adults with type 2 diabetes reported differences in total body fat mass between study groups at 36 weeks.<\/p>\n
What are the Side Effects of Retatrutide?<\/strong><\/p>\n Across clinical studies, the most commonly reported adverse events were gastrointestinal symptoms such as nausea, vomiting, and diarrhea.<\/p>\n For inquiries regarding availability, import process, or cost of Retatrutide Injection :<\/strong> NEWS\/UPDATES<\/p>\n India Pharma Network acts solely as a facilitator for Retatrutide Injection access. IPN does not manufacture, sell, or promote medicines and does not provide medical advice. All imports are:<\/p>\n The prescribing physician remains solely responsible for dosage, therapy, and clinical decisions.<\/p>\n","protected":false},"excerpt":{"rendered":" It is a single molecule that acts as a triple agonist for GLP-1, GIP, and glucagon receptors<\/strong>.\u00a0It is a powerful \u201ctriple-threat\u201d metabolic peptide for weight loss and obesity management.<\/strong><\/p>\n Retatrutide must always be used under the supervision of a Registered Medical Practitioner (RMP).<\/em><\/strong><\/p>\n IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to Retatrutide Injection for personal use.\u00a0<\/strong>For any queries, including information regarding the cost of the pharmaceutical product in India<\/strong>, please contact the IPN Healthcare Support Team via email or at the following numbers:\u00a0Mobile\/WhatsApp:<\/strong>\u00a0Mr. Tarun: +91 9891 296 838 | \u00a0Mr. Neeraj: +91 9811 747 774.<\/p>\n","protected":false},"featured_media":10646,"template":"","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":""},"product_brand":[],"product_cat":[207,212,208],"product_tag":[],"class_list":{"0":"post-10645","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-diabetes","7":"product_cat-cardiology","8":"product_cat-obesity","10":"first","11":"instock","12":"shipping-taxable","13":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product\/10645","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/types\/product"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/media\/10646"}],"wp:attachment":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/media?parent=10645"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_brand?post=10645"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_cat?post=10645"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_tag?post=10645"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Contact IPN \u2013 Retatrutide Access in India<\/h4>\n
\nIndia Pharma Network (IPN)<\/strong>\u00a0: Headquartered in\u00a0New Delhi<\/strong>, with branch offices in\u00a0Delhi, Gurugram, Mumbai, Bangalore, Kolkata, Chennai, Pune, Ahmedabad, Hyderabad, Chandigarh, Jaipur\u00a0<\/strong>and\u00a0Lucknow<\/strong>, IPN supports medicine imports across India on a\u00a0Named Patient Import Basis<\/strong>\u00a0and for\u00a0personal use only<\/strong>.\u00a0Mobile\/WhatsApp:<\/strong>\u00a0Mr. Tarun: +91 9891 296 838 | \u00a0Mr. Neeraj: +91 9811 747 774.\u00a0Email:<\/strong>\u00a0info@indianpharmanetwork.co.in<\/a><\/p>\n\n
Compliance & Disclaimer<\/h5>\n
\n
Retatrutide Injection \u2013 obesity and type 2 diabetes drug therapy in India.<\/h2>\n
\n\n
\n Brand Name:<\/strong><\/td>\n Retatrutide Pen<\/td>\n<\/tr>\n \n Strength:<\/strong><\/td>\n Triple Agonist for GLP-1, GIP, and Glucagon Receptors<\/td>\n<\/tr>\n \n Manufacturer:<\/strong><\/td>\n Regenmed<\/td>\n<\/tr>\n \n Price:<\/strong><\/td>\n On Request<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n Retatrutide is an investigational drug,\u00a0currently only available through legitimate clinical trials, with Phase 3 trials concluding in 2026.<\/h3>\n